These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 33569817)

  • 1. CRISPR/Cas technology as a promising weapon to combat viral infections.
    Escalona-Noguero C; López-Valls M; Sot B
    Bioessays; 2021 Apr; 43(4):e2000315. PubMed ID: 33569817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
    Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
    Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas based genome editing for eradication of human viruses.
    Solanki D; Murjani K; Singh V
    Prog Mol Biol Transl Sci; 2024; 208():43-58. PubMed ID: 39266187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions.
    Jamehdor S; Pajouhanfar S; Saba S; Uzan G; Teimoori A; Naserian S
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant Viruses: From Targets to Tools for CRISPR.
    Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR systems: Novel approaches for detection and combating COVID-19.
    Safari F; Afarid M; Rastegari B; Borhani-Haghighi A; Barekati-Mowahed M; Behzad-Behbahani A
    Virus Res; 2021 Mar; 294():198282. PubMed ID: 33428981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
    Soppe JA; Lebbink RJ
    Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
    Moyo B; Bloom K; Scott T; Ely A; Arbuthnot P
    Virus Res; 2018 Jan; 244():311-320. PubMed ID: 28087399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas based antiviral strategies against HIV-1.
    Wang G; Zhao N; Berkhout B; Das AT
    Virus Res; 2018 Jan; 244():321-332. PubMed ID: 28760348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.
    Banerjee A; Mukherjee S; Maji BK
    Exp Biol Med (Maywood); 2021 Jul; 246(14):1643-1649. PubMed ID: 33899542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics.
    Zhou L; Simonian AL
    Annu Rev Biomed Eng; 2024 Jul; 26(1):247-272. PubMed ID: 38346278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview: CRISPR/Cas-based gene editing for viral vaccine development.
    Bhujbal S; Bhujbal R; Giram P
    Expert Rev Vaccines; 2022 Nov; 21(11):1581-1593. PubMed ID: 35959589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR/Cas9 genome editing methodology as a weapon against human viruses.
    White MK; Hu W; Khalili K
    Discov Med; 2015 Apr; 19(105):255-62. PubMed ID: 25977188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.
    Zhan Y; Li XP; Yin JY
    Int J Biol Sci; 2021; 17(8):2080-2088. PubMed ID: 34131407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections.
    Najafi S; Tan SC; Aghamiri S; Raee P; Ebrahimi Z; Jahromi ZK; Rahmati Y; Sadri Nahand J; Piroozmand A; Jajarmi V; Mirzaei H
    Biomed Pharmacother; 2022 Apr; 148():112743. PubMed ID: 35228065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.
    Chen S; Yu X; Guo D
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29337866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.